STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 116 filers reported holding STOKE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.73 and the average weighting 1.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 10,843,681 | $146,498,130 | 99.89% |
| Lynx1 Capital Management LP | 5,185,191 | $70,051,931 | 25.27% |
| Redmile Group, LLC | 4,721,054 | $63,781,440 | 3.86% |
| Birchview Capital, LP | 210,000 | $2,837,100 | 2.63% |
| COWEN AND COMPANY, LLC | 3,365,744 | $45,471,201 | 1.25% |
| Logos Global Management LP | 1,050,000 | $14,185,500 | 1.15% |
| RTW INVESTMENTS, LP | 4,224,838 | $57,077,561 | 0.88% |
| Baker Brothers Advisors | 4,368,443 | $59,017,665 | 0.75% |
| DAFNA Capital Management LLC | 207,427 | $2,802,339 | 0.67% |
| Sio Capital Management, LLC | 175,301 | $2,368,317 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 141,518 | $1,911,908 | 0.45% |
| Cormorant Asset Management, LP | 427,163 | $5,770,972 | 0.33% |
| Granahan Investment Management | 598,401 | $8,084,398 | 0.32% |
| Palo Alto Investors LP | 125,861 | $1,700,382 | 0.20% |
| Fort Point Capital Partners LLC | 75,429 | $1,019,046 | 0.13% |
| CHASE INVESTMENT COUNSEL CORP | 20,738 | $280 | 0.10% |
| EAM Investors, LLC | 37,637 | $508,476 | 0.08% |
| Eversept Partners, LP | 61,277 | $827,852 | 0.06% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1,387,200 | $18,741,072 | 0.05% |
| Assenagon Asset Management S.A. | 1,468,202 | $19,835,409 | 0.04% |
External links
This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2024. To view STOKE THERAPEUTICS INC's shareholder history, click here.